Connect your AI

Bausch Health Companies BHC Price / sales

Price / sales at other companies

PBH

Prestige Consumer HealthcarePBH

2.6×-1.2×

Bausch + LombBLCO

1.1×0.0×

Johnson & JohnsonJNJ

6.1×+1.6×

AbbVieABBV

6.1×-0.3×

OrganonOGN

0.3×-0.4×

HRO

HarrowHROW

4.9×+0.4×

Other financials

Income statement

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

Market cap$1.79B-15.9%

Enterprise value$21.24B-5.6%

Profitability

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Calculated from Bausch Health Companies’s reported figures.

market cap/total revenue=0.2×

Based on the most recent quarter.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Bausch Health Companies's price / sales?: Bausch Health Companies (BHC) reported price / sales of 0.2× in Q1 2026.
How has Bausch Health Companies's price / sales changed year-over-year?: Bausch Health Companies's price / sales decreased by 22.3% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for Bausch Health Companies's price / sales?: Over 5 years (2020 to 2025), Bausch Health Companies's price / sales has grown at a -23.4% compound annual growth rate (CAGR), from 1× to 0.3×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.